津药药业
(600488)
| 流通市值：56.45亿 | | | 总市值：56.45亿 |
| 流通股本：10.92亿 | | | 总股本：10.92亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,864,212,165.72 | 1,313,057,171.63 | 608,114,103.87 | 2,908,035,191.99 |
| 营业总成本 | 1,754,102,537.8 | 1,194,468,598.58 | 567,269,140.48 | 2,652,987,006.09 |
| 其他经营收益 | | | | |
| 营业利润 | 83,587,045 | 67,266,838.72 | 21,910,504.97 | 189,755,227.57 |
| 利润总额 | 83,015,263.67 | 67,327,805.93 | 21,610,397.87 | 122,109,769.75 |
| 净利润 | 63,244,390.43 | 51,406,494.21 | 15,254,425.94 | 122,054,932.22 |
| 每股收益 | | | | |
| 其他综合收益 | 3,462,231.25 | 940,720.35 | -450,224.21 | 17,047,018.45 |
| 综合收益总额 | 66,706,621.68 | 52,347,214.56 | 14,804,201.73 | 139,101,950.67 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,004,656,073.29 | 2,253,275,829.16 | 2,083,306,683.89 | 2,209,586,504.68 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,553,407,437.03 | 3,496,209,792.49 | 3,551,296,940.59 | 3,678,769,433.97 |
| 资产总计 | 5,558,063,510.32 | 5,749,485,621.65 | 5,634,603,624.48 | 5,888,355,938.65 |
| 流动负债: | | | | |
| 流动负债合计 | 1,417,567,517.86 | 1,600,334,955.05 | 1,003,640,590.52 | 1,169,361,289.24 |
| 非流动负债: | | | | |
| 非流动负债合计 | 283,771,859.76 | 304,721,788.19 | 720,043,828.21 | 697,698,231.91 |
| 负债合计 | 1,701,339,377.62 | 1,905,056,743.24 | 1,723,684,418.73 | 1,867,059,521.15 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,026,751,605.28 | 3,023,768,744.19 | 3,049,148,585.52 | 3,160,888,912.17 |
| 股东权益合计 | 3,856,724,132.7 | 3,844,428,878.41 | 3,910,919,205.75 | 4,021,296,417.5 |
| 负债和股东权益合计 | 5,558,063,510.32 | 5,749,485,621.65 | 5,634,603,624.48 | 5,888,355,938.65 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,773,276,710.56 | 1,235,336,879.98 | 584,702,709.19 | 2,574,449,481.34 |
| 经营活动现金流出小计 | 1,473,587,457.52 | 1,043,558,577.12 | 596,055,010.8 | 2,437,969,818.38 |
| 经营活动产生的现金流量净额 | 299,689,253.04 | 191,778,302.86 | -11,352,301.61 | 136,479,662.96 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 995,826.76 | 315,305 | 13,500 | 127,349,138.85 |
| 投资活动现金流出小计 | 157,571,867.51 | 17,712,135.31 | 6,685,345.2 | 76,310,613.05 |
| 投资活动产生的现金流量净额 | -156,576,040.75 | -17,396,830.31 | -6,671,845.2 | 51,038,525.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 100,000,000 | 100,000,000 | 26,000,000 | 329,129,071.2 |
| 筹资活动现金流出小计 | 372,387,355.8 | 267,128,299.68 | 128,110,253.12 | 315,050,892.82 |
| 筹资活动产生的现金流量净额 | -272,387,355.8 | -167,128,299.68 | -102,110,253.12 | 14,078,178.38 |
| 汇率变动对现金及现金等价物的影响 | -6,132,946.76 | -3,990,465.81 | -1,952,594.27 | 10,064.63 |
| 现金及现金等价物净增加额 | -135,407,090.27 | 3,262,707.06 | -122,086,994.2 | 201,606,431.77 |
| 期末现金及现金等价物余额 | 673,382,536.09 | 799,435,736.46 | 674,086,035.2 | 796,173,029.4 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 3,262,707.06 | - | 201,606,431.77 |